These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37847063)

  • 1. Bioinspired immuno-radio-enhancers toward synergistic nanomedicine through radiation-induced abscopal effects and immunocheckpoint blockade therapies.
    Zhang P; Chen H; Chen C; Liu X; Cheng H; Wu Y; Wang X; Liu G; Zeng Y
    Biomater Sci; 2023 Nov; 11(22):7327-7338. PubMed ID: 37847063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
    Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
    J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor microenvironment responsive biodegradable CaCO
    Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
    Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional MnO
    Yang G; Ji J; Liu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1720. PubMed ID: 33908171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases.
    Liang R; Liu L; He H; Chen Z; Han Z; Luo Z; Wu Z; Zheng M; Ma Y; Cai L
    Biomaterials; 2018 Sep; 177():149-160. PubMed ID: 29890364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia.
    Wang X; Huang R; Wu W; Xiong J; Wen Q; Zeng Y; Chen T; Li J; Zhang C; Zhong JF; Yang S; Zhang X
    Acta Biomater; 2023 Feb; 157():381-394. PubMed ID: 36375786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy.
    Xu F; Zhu J; Lin L; Zhang C; Sun W; Fan Y; Yin F; van Hest JCM; Wang H; Du L; Shi X
    Theranostics; 2020; 10(10):4349-4358. PubMed ID: 32292499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors.
    Tan YN; Huang JD; Li YP; Li SS; Luo M; Luo J; Lee AW; Fu L; Hu FQ; Guan XY
    Adv Healthc Mater; 2022 Mar; 11(6):e2101496. PubMed ID: 34878725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNAzyme-Assisted Nano-Herb Delivery System for Multiple Tumor Immune Activation.
    Du S; Chen C; Qu S; Song H; Yang J; Li Y; Liu K; Lu Q; Luo W; Wang R; Guan X; Song Y; Han X
    Small; 2022 Nov; 18(45):e2203942. PubMed ID: 36156383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
    Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
    J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedles loaded with anti-PD-1-cisplatin nanoparticles for synergistic cancer immuno-chemotherapy.
    Lan X; Zhu W; Huang X; Yu Y; Xiao H; Jin L; Pu JJ; Xie X; She J; Lui VWY; Chen HJ; Su YX
    Nanoscale; 2020 Sep; 12(36):18885-18898. PubMed ID: 32902555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin-Loaded and Manganese Dioxide-Coated Polydopamine Nanomedicine Used for Magnetic Resonance Imaging Diagnosis and Chemo-Photothermal Therapy for Lung Cancer.
    Su M; Chen Y; Jia L; Zhang Z
    Int J Nanomedicine; 2022; 17():6687-6705. PubMed ID: 36597434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese dioxide (MnO
    Zhu D; Zhu XH; Ren SZ; Lu YD; Zhu HL
    J Drug Target; 2021 Nov; 29(9):911-924. PubMed ID: 33063538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.